Status:
COMPLETED
Recurrence of Odontogenic Keratocyst
Lead Sponsor:
Tanta University
Conditions:
Odontogenic Cyst
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
The aim of current cross over clinical trial is to evaluate the effect of topical 5-FU as adjunct therapy in reducing risk of the recurrence of OKCs
Detailed Description
The main inclusion criteria in this study will be 48 patients with biopsy proved odontogenic keratocyst with no relevant systemic diseases which might affect healing process. patients will be treated ...
Eligibility Criteria
Inclusion
- patients with biopsy proved odontogenic keratocyst
Exclusion
- relevant systemic diseases which might affect healing process.
Key Trial Info
Start Date :
December 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06071806
Start Date
December 2 2022
End Date
June 30 2024
Last Update
February 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, Gharbia Governorate, Egypt, 3111